Is T. Rowe Price Personal Strategy Growth (TRSGX) a Strong Mutual Fund Pick Right Now?
Werte in diesem Artikel
If investors are looking at the Index fund category, T. Rowe Price Personal Strategy Growth (TRSGX) could be a potential option. TRSGX carries a Zacks Mutual Fund Rank of 2 (Buy), which is based on various forecasting factors like size, cost, and past performance.History of Fund/ManagerT. Rowe Price is based in Baltimore, MD, and is the manager of TRSGX. Since T. Rowe Price Personal Strategy Growth made its debut in July of 1994, TRSGX has garnered more than $1.33 billion in assets. A team of investment professionals is the fund's current manager.PerformanceInvestors naturally seek funds with strong performance. TRSGX has a 5-year annualized total return of 9.69%, and it sits in the top third among its category peers. Investors who prefer analyzing shorter time frames should look at its 3-year annualized total return of 12.74%, which places it in the top third during this time-frame.It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, TRSGX's standard deviation comes in at 12.12%, compared to the category average of 12.79%. Looking at the past 5 years, the fund's standard deviation is 12.69% compared to the category average of 12.23%. This makes the fund more volatile than its peers over the past half-decade.Risk FactorsInvestors should note that the fund has a 5-year beta of 0.75, which means it is hypothetically less volatile than the market at large. Because alpha represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which is the S&P 500 in this case, one should pay attention to this metric as well. Over the past 5 years, the fund has a negative alpha of -3.13. This means that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.ExpensesCosts are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, TRSGX is a no load fund. It has an expense ratio of 0.62% compared to the category average of 0.82%. From a cost perspective, TRSGX is actually cheaper than its peers.While the minimum initial investment for the product is $2,500, investors should also note that each subsequent investment needs to be at least $100.Fees charged by investment advisors have not been taken into consideration. Returns would be less if those were included.Bottom LineOverall, T. Rowe Price Personal Strategy Growth ( TRSGX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively strong performance, average downside risk, and lower fees, this fund looks like a good potential choice for investors right now.For additional information on this product, or to compare it to other mutual funds in the Index, make sure to go to www.zacks.com/funds/mutual-funds for additional information. If you want to check out our stock reports as well, make sure to go to Zacks.com to see all of the great tools we have to offer, including our time-tested Zacks Rank.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (TRSGX): Fund Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Strategy (ex MicroStrategy) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Mutual
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Mutual
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Strategy (ex MicroStrategy)
Analysen zu Strategy (ex MicroStrategy)
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2019 | Microstrategy A Buy | BWS Financial | |
27.10.2017 | Microstrategy A Buy | Mizuho | |
28.07.2017 | Microstrategy A Hold | Deutsche Bank AG | |
16.11.2016 | Microstrategy A Buy | Mizuho | |
11.01.2016 | Microstrateg a Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
11.02.2019 | Microstrategy A Buy | BWS Financial | |
27.10.2017 | Microstrategy A Buy | Mizuho | |
16.11.2016 | Microstrategy A Buy | Mizuho | |
11.01.2016 | Microstrateg a Buy | Deutsche Bank AG | |
11.12.2015 | Microstrateg a Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
28.07.2017 | Microstrategy A Hold | Deutsche Bank AG | |
19.10.2015 | Microstrateg a Hold | Lake Street | |
31.10.2012 | Microstrateg a neutral | ROTH Capital Partners, LLC | |
30.10.2012 | Microstrateg a neutral | UBS AG | |
31.07.2012 | Microstrateg a neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
16.03.2005 | Update Microstrategy Inc.: Sell | Wedbush Morgan | |
09.02.2005 | Update Microstrategy Inc.: Sell | Deutsche Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Strategy (ex MicroStrategy) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen